2023
DOI: 10.1055/s-0043-1764467
|View full text |Cite
|
Sign up to set email alerts
|

The Post–Venous Thromboembolism Functional Status Scale: From Call to Action to Application in Research, Extension to COVID-19 Patients, and Its Use in Clinical Practice

Abstract: A broad spectrum of long-term sequelae may be present in venous thromboembolism (VTE) survivors, affecting their quality of life and functioning. To monitor recovery and improve the prognosis of patients with persistent functional limitations, the development of a new outcome measure that could better capture the consequences of VTE was an unmet need. Starting as a call to action, the Post-VTE Functional Status (PVFS) scale was developed to meet this need. The PVFS scale is an easy-to-use clinical tool to meas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 63 publications
0
2
0
Order By: Relevance
“…To this end, a COVID-19-specific post-VTE functional status scale has recently been developed for defining the functional outcome of COVID-19 patients who have suffered from VTE, focusing on a number of important aspects of daily life, such as tasks or activities at home or work, persistent symptoms, pain, and anxiety levels. 19 In terms of key predictors, a number of potential factors can be inferred from recent clinical studies, including older age, male sex, hospitalization (both in terms of duration and intensity of treatment), lack of thromboprophylaxis upon discharge along with the presence of prothrombotic conditions (particularly cardiovascular disorders and thrombophilia) (►Table 1). Patients who have these factors should be monitored more closely to intercept any thrombosis that may occur in a post-COVID time-related manner but may also benefit from extended thromboprophylaxis (as recently proposed 20 ) and/or antiplatelet therapy, the duration of which should be carefully calibrated on the basis of evidence-based data, as yet to be obtained in future randomized clinical trials.…”
Section: Conclusion and Future Implicationsmentioning
confidence: 99%
“…To this end, a COVID-19-specific post-VTE functional status scale has recently been developed for defining the functional outcome of COVID-19 patients who have suffered from VTE, focusing on a number of important aspects of daily life, such as tasks or activities at home or work, persistent symptoms, pain, and anxiety levels. 19 In terms of key predictors, a number of potential factors can be inferred from recent clinical studies, including older age, male sex, hospitalization (both in terms of duration and intensity of treatment), lack of thromboprophylaxis upon discharge along with the presence of prothrombotic conditions (particularly cardiovascular disorders and thrombophilia) (►Table 1). Patients who have these factors should be monitored more closely to intercept any thrombosis that may occur in a post-COVID time-related manner but may also benefit from extended thromboprophylaxis (as recently proposed 20 ) and/or antiplatelet therapy, the duration of which should be carefully calibrated on the basis of evidence-based data, as yet to be obtained in future randomized clinical trials.…”
Section: Conclusion and Future Implicationsmentioning
confidence: 99%
“…The most recent arising publications are also listed in the reference list for the benefit of the readership. 3 4 5 6 7 8 9 10 11 12 13 I have mentioned several times my personal gratification that most of the papers from earlier years have subsequently appeared in several annual top 100 listings. Of further interest, some of these papers or the young investigators themselves have subsequently won one of the Most Popular awards (see Table 1 for a list of prior editorials on these awards).…”
Section: Tablementioning
confidence: 99%